Regulation of fetoplacental vascular bed by hypoxia

Physiological Research

Volumn 58, Issue SUPPL.2, 2009, Pages 87-94

  Hampl, V ^a   Jakoubek, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Hypoxia; Intrauterine growth restriction; Ion channels; Placenta; Vasoconstriction

Indexed keywords

ION CHANNEL;

ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; FEMALE; FETUS HYPOXIA; HEMODYNAMICS; HUMAN; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; FEMALE; FETAL GROWTH RETARDATION; FETAL HYPOXIA; HEMODYNAMICS; HUMANS; ION CHANNELS; MUSCLE, SMOOTH, VASCULAR; PLACENTAL CIRCULATION; PREGNANCY; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 77949530224     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (49)

1. ARBEILLE P: Fetal arterial Doppler-IUGR and hypoxia. Eur J Obstet Gynecol Reprod Biol 75: 51-53, 1997.
2. ARCHER S, HAMPL V, MCKENZIE Z, NELSON D, HUANG J, SHULTZ P, WEIR EK: Role of endothelial-derived nitric oxide in normal and hypertensive pulmonary vasculature. Semin Respir Med 15: 179-189, 1994.
3. 2 sensors, and controversies. News Physiol Sci 17: 131-137, 2002.
4. BACHMAIER N, LINNEMANN K, MAY K, WARZOK R, KUNO S, NIEMEYER M, BALK S, FUSCH C: Ultrastructure of human placental tissue after 6 h of normoxic and hypoxic dual in vitro placental perfusion. Placenta 28: 861-867, 2007.
5. BANASOVÁ A, MAXOVÁ H, HAMPL V, VÍZEK M, POVÝŠILOVÁ V, NOVOTNÁ J, VAJNEROVÁ O, HNILIČKOVÁ O, HERGET J: Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia. Respiration 76: 102-107, 2008.
6. BĚLOHLÁVKOVÁ S, ŠIMÁK J, KOKEŠOVÁ A, HNILIČKOVÁ O, HAMPL V: Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. J Appl Physiol 91: 755-761, 2001.
7. BRODSKY D, CHRISTOU H: Current concepts in intrauterine growth restriction. J Intens Care Med 19: 307-319, 2004.
8. BYRNE BM, HOWARD RB, MORROW RJ, WHITELEY KJ, ADAMSON SL: Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction. Placenta 18: 627-634, 1997.
9. CHALLIS DE, PFARRER CD, RITCHIE JWK, KOREN G, ADAMSON SL: Glucose metabolism is elevated and vascular resistance and maternofetal transfer is normal in perfused placental cotyledons from severely growthrestricted fetuses. Pediatr Res 47: 309-315, 2000.
10. DEMPSIE Y, MACLEAN MR: Pulmonary hypertension: therapeutic targets within the serotonin system. Br J Pharmacol 155: 455-462, 2008.
11. ESPINOZA J, SEBIRE N, MCAULIFFE F, KRAMPL E, NICOLAIDES K: Placental villus morphology in relation to maternal hypoxia at high altitude. Placenta 22: 606-608, 2001.
12. FAGAN KA, OKA M, BAUER NR, GEBB SA, IVY DD, MORRIS KG, MCMURTRY IF: Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol 287: L656-L664, 2004.
13. FARBER HW, LOSCALZO J: Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665, 2004.
14. FIGUEROA R, OMAR HA, TEJANI N, WOLIN MS: Gestational diabetes alters human placental vascular responses to changes in oxygen tension. Am J Obstet Gynecol 168: 1616-1622, 1993.
15. HAMPL V, HERGET J: Possible mechanisms of oxygen sensing in the pulmonary circulation. Physiol Res 40: 463-470, 1991.
16. HAMPL V, HERGET J: Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80: 1337-1372, 2000.
17. HAMPL V, BÍBOVÁ J, STRANÁK Z, WU X, MICHELAKIS ED, HASHIMOTO K, ARCHER SL: Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol 283: H2440-H2449, 2002.
18. HAMPL V, BÍBOVÁ J, BANASOVÁ A, UHLÍK J, MIKOVÁ D, HNILIČKOVÁ O, LACHMANOVÁ V, HERGET J: Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension. Am J Physiol 290: L11-L20, 2006.
19. HAMPL V, JAKOUBEK V, KLESCOVÁ A: Oxygen sensing in fetoplacental vessels (abstract). Acta Physiol 191: 20 (SF12-54), 2007.
20. HERGET J, HAMPL V: Pulmonary circulation. In: Biomechanics of the Cardiovascular System. BB ŠRÁMEK, J VALENTA, F KLIMEŠ (eds), Czech Technical University Press, Prague, 1995, pp 327-336.
21. HERGET J, NOVOTNÁ J, BÍBOVÁ J, POVÝŠILOVÁ V, VANKOVÁ M, HAMPL V: Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats. Am J Physiol 285: L199-L208, 2003.
22. HOWARD R: Control of human placental blood flow. Med Hypotheses 23: 51-58, 1987.
23. HOWARD RB, HOSOKAWA T, MAGUIRE H: Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 157: 1261-1266, 1987.
24. JAKOUBEK V, BÍBOVÁ J, HAMPL V: Voltage-gated calcium channels mediate hypoxic vasoconstriction in the human placenta. Placenta 27: 1030-1033, 2006.
25. JAKOUBEK V, BÍBOVÁ J, VENCLÍKOVÁ K, TRNKOVÁ A, HERGET J, HAMPL V: Chronic hypoxia increases fetoplacental vascular resistance and vasoconstrictor reactivity in the rat. Am J Physiol 294: H1638-H1644, 2008.
26. JAMES JL, STONE PR, CHAMLEY LW: The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update 12: 137-144, 2006.
27. KHALID M, ALI M, ALI K: Full-term birth weight and placental morphology at high and low altitude. Int J Gynaecol Obstet 57: 259-265, 1997.
28. LACHMANOVÁ V, HNILIČKOVÁ O, POVÝŠILOVÁ V, HAMPL V, HERGET J: N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia. Life Sci 77: 175-182, 2005.
29. MCLAUGHLIN VV, MCGOON MD: Pulmonary arterial hypertension. Circulation 114: 1417-1431, 2006.
30. MOORE LG: Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol 4: 141-156, 2003.
31. MYATT L: Control of vascular resistance in the human placenta. Placenta 13: 329-341, 1992.
32. OSOL G, MANDALA M: Maternal uterine vascular remodeling during pregnancy. Physiology 24: 58-71, 2009.
33. PARKER TA, ROE G, GROVER TR, ABMAN SH: Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol 291: L976-L982, 2006.
34. PAVEK P, STAUD F, FENDRICH Z, SKLENAROVA H, LIBRA A, NOVOTNA M, KOPECKY M, NOBILIS M, SEMECKY V: Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J Pharmacol Exp Ther 305: 1239-1250, 2003.
35. POSTON L, MCCARTHY AL, RITTER JM: Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65: 215-239, 1995.
36. POWER GG, DALE PS, NELSON PS: Distribution of maternal and fetal blood flow within cotyledons of the sheep placenta. Am J Physiol 241: H486-H496, 1981.
37. RAMASUBRAMANIAN R, JOHNSON RF, DOWNING JW, MINZTER BH, PASCHALL RL: Hypoxemic fetoplacental vasoconstriction: a graduated response to reduced oxygen conditions in the human placenta. Anesth Analg 103: 439-442, 2006.
38. REYNOLDS LP, CATON JS, REDMER DA, GRAZUL-BILSKA AT, VONNAHME KA, BOROWICZ PP, LUTHER JS, WALLACE JM, WU G, SPENCER TE: Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol Lond 572: 51-58, 2006.
39. SCHEFFEN I, KAUFMANN P, PHILIPPENS L, LEISER R, GEISEN C, MOTTAGHY K: Alterations of the fetal capillary bed in the guinea pig placenta following long-term hypoxia. Adv Exp Med Biol 277: 779-790, 1990.
40. STAUD F, VACKOVA Z, POSPECHOVA K, PAVEK P, CECKOVA M, LIBRA A, CYGALOVA L, NACHTIGAL P, FENDRICH Z: Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 319: 53-62, 2006.
41. STOCK M, ANDERSON DF, PHERNETTON TM, MCLAUGHLIN MK, RANKIN JHG: Vascular response of the fetal placenta to local occlusion of the maternal placental vasculature. J Dev Physiol 2: 339-346, 1980.
42. STRASZEWSKI-CHAVEZ SL, ABRAHAMS VM, MOR G: The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 26: 877-897, 2005.
43. ŠTULC J, ŠTULCOVÁ B, ŠVIHOVEC J: Transport of calcium across the dually perfused placenta of the rat. J Physiol Lond 420: 295-311, 1990.
44. TISSOT VAN PATOT MC, BENDRICK-PEART J, BECKEY VE, SERKOVA N, ZWERDLINGER L: Greater vascularity, lowered HIF-1/DNA binding, and elevated GSH as markers of adaptation to in vivo chronic hypoxia. Am J Physiol 287: L525-L532, 2004.
45. VAJNER L, VYTÁŠEK R, LACHMANNOVÁ V, UHLÍK J, KONRÁDOVÁ V, NOVOTNÁ J, HAMPL V, HERGET J: Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats. Int J Exp Pathol 87: 383-391, 2006.
46. WAREING M, BAI X, SEGHIER F, TURNER CM, GREENWOOD SL, BAKER PN, TAGGART MJ, FYFE GK: Expression and function of potassium channels in the human placental vasculature. Am J Physiol 291: R437-R446, 2006a.
47. WAREING M, GREENWOOD SL, BAKER PN: Reactivity of human placental chorionic plate vessels is modified by level of oxygenation: differences between arteries and veins. Placenta 27: 42-48, 2006b.
48. ZAIDI SHE, YOU X-M, CIURA S, HUSAIN M, RABINOVITCH M: Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105: 516-521, 2002.
49. ZAMUDIO S: The placenta at high altitude. High Alt Med Biol 4: 171-191, 2003.